EcoDrugPlus

Cytochrome P450 405a6

Ensembl ID : HMEL016674
Gene Symbol: CYP405A6
1 External references
150 Possible Orthologues:

Cytochrome P450 4cg10

Ensembl ID : HMEL003582
Gene Symbol: CYP4CG10
1 External references
151 Possible Orthologues:

Cytochrome P450 4cg11

Ensembl ID : HMEL008768
Gene Symbol: CYP4CG11
1 External references
246 Possible Orthologues:

Cytochrome P450 4cg12

Ensembl ID : HMEL008772
Gene Symbol: CYP4CG12
1 External references
246 Possible Orthologues:

Cytochrome P450 4cg13

Ensembl ID : HMEL003584
Gene Symbol: CYP4CG13
1 External references
155 Possible Orthologues:

Cytochrome P450 4cg4

Ensembl ID : HMEL008770
Gene Symbol: CYP4CG4
1 External references
151 Possible Orthologues:

Cytochrome P450 4cg5

Ensembl ID : HMEL003583
Gene Symbol: CYP4CG5
1 External references
149 Possible Orthologues:

Cytochrome P450 4cg6

Ensembl ID : HMEL010693
Gene Symbol: CYP4CG6
1 External references
152 Possible Orthologues:

Cytochrome P450 4cg7

Ensembl ID : HMEL002471
Gene Symbol: CYP4CG7
1 External references
152 Possible Orthologues:

Cytochrome P450 4cg9

Ensembl ID : HMEL003581
Gene Symbol: CYP4CG9
1 External references
151 Possible Orthologues:

Cytochrome P450 4g71

Ensembl ID : HMEL016705
Gene Symbol: CYP4G71
1 External references
241 Possible Orthologues:

Cytochrome P450 4g73

Ensembl ID : HMEL006588
Gene Symbol: CYP4G73
1 External references
237 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).